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ABSTRACT
Short interfering RNAs (siRNAs) are widely used as
tool for gene inactivation in basic research and ther-
apeutic applications. One of the major shortcom-
ings of siRNA experiments are sequence-specific off-
target effects. Such effects are largely unpredictable
because siRNAs can affect partially complementary
sequences and function like microRNAs (miRNAs),
which inhibit gene expression on mRNA stability or
translational levels. Here we demonstrate that novel,
enzymatically generated siRNA pools––referred to as
siPools––containing up to 60 accurately defined siR-
NAs eliminate off-target effects. This is achieved by
the low concentration of each individual siRNA di-
luting sequence-specific off-target effects below de-
tection limits. In fact, whole transcriptome analyses
reveal that single siRNA transfections can severely
affect global gene expression. However, when com-
plex siRNA pools are transfected, almost no tran-
scriptome alterations are observed. Taken together,
we present enzymatically produced complex but ac-
curately defined siRNA pools with potent on-target
silencing but without detectable off-target effects.
INTRODUCTION
RNA interference (RNAi) is not only a potent cellular path-
way to silence endogenous or exogenous genes but is also a
widely used tool for sequence-specific gene knockdown (1).
The trigger of RNAi is typically long double stranded (ds)
RNA, which is processed to short interfering RNAs (siR-
NAs) by the cellular RNase III enzyme Dicer. SiRNAs are
21 nucleotides (nt) long dsRNAs, with 5′ phosphates and
2 nt 3′ overhangs (2,3). The strand that is complementary
to the target RNAs is referred to as the guide or antisense
strand, while the other strand is known as the passenger
or sense strand. In further loading steps, which require the
help of heat shock proteins, the guide strand is incorporated
into the RNA-induced silencing complex (RISC) (4–6). The
guide strand targets RISC to perfectly complementary tar-
get sites located on otherRNAs leading to sequence-specific
cleavage and further degradation of the target RNA (2).
The core protein component of RISC and direct inter-
action partner of siRNAs is a member of the Argonaute
(Ago) protein family. Ago proteins are characterized by
PAZ, MID and PIWI domains (7–9). The PAZ domain
binds the 3′ end and the MID domain anchors the 5′ end
of the siRNA. The PIWI domain is structurally similar
to RNase H and indeed some Ago proteins possess en-
donuclease activity (10). These proteins are referred to as
‘slicers’ and facilitate the sequence-specific cleavage event
in RNAi. The four humanArgonaute proteins Ago1, Ago2,
Ago3 and Ago4 are expressed in human somatic cells and
interact with siRNAs (9,11). Although these proteins are
very similar, onlyAgo2 is endonucleolytically active (12,13).
Ago2 not only cleaves the complementary target RNA but
uses its cleavage activity also during RISC loading: Ago2
binds to the ds siRNA and cleaves the passenger strand
leading to faster and more efficient loading of the siRNA
into Ago2-containing RISC complexes (14–16). Although
less efficient, non-catalytic Ago proteins load siRNA guide
strands in RNAi experiments (17,18) and it has been re-
ported that non-catalytic Ago proteins can contribute to the
knockdown as well (19).
After an initial hype and the hope that RNAi develops
into a potent novel strategy for therapy, it became clear
that several problems associated with RNAi experiments
have not been solved. Besides delivery issues in RNAi-
based therapeutic approaches, one of the major problems
of siRNAs are off-target effects (20,21). Most siRNAs
not only target their complementary on-targets but also
an unknown number of off-targets. Off-target effects are
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sequence-specific and intrinsic to each siRNA molecule.
Such effects mainly occur because of endogenous gene si-
lencing pathways based on microRNAs (miRNAs) (22,23).
MiRNAs are expressed from specific genes and inhibit the
expression of target genes by binding to Ago proteins and
hybridizing to only partially complementary target sites,
which are typically located in the 3′ untranslated region
(UTR) of target mRNAs (24). MiRNA-guided inhibition
leads to translational silencing or deadenylation-induced
mRNA decay (25). Nucleotides 2–8 of the miRNA com-
prise the ‘seed region’ and base pair perfectly with the target
mRNA. The remaining nucleotides are less important for
miRNA-guided targeting. Since siRNAs and miRNAs are
indistinguishable within the cell, siRNAs can function like
miRNAs and target mRNAs via their seed region. As the
seed regions of siRNAs commonlymatch thousands ofmR-
NAs, off-target effects are largely unpredictable. These ef-
fects are very common and vary from sequence to sequence.
In addition, off-target effects can be caused by sequence-
specific immune activation events or by a potential com-
petition of siRNAs with endogenous miRNAs for effector
proteins.
Here, we report the development of a new generation of
siRNA tools without off-target effects. Using an enzymatic
approach, we generate complex pools of accurately defined
siRNAs.While synergistically silencing one single on-target
gene, each individual siRNA is present at very low concen-
trations, effectively diluting off-target effects below detec-
tion limits. The novel enzymatic strategy allows for the free
combination of individually selected siRNA sequences to
obtain optimal siRNA pools. We refer to our novel siRNA
pools as siPools and overcome off-target effects, the major
shortcoming of classical siRNA reagents.
MATERIALS AND METHODS
Generation of complex siRNA pools
DNA templates were synthesized by GeneArt (Life Tech-
nologies). SiPool templates were in vitro transcribed using
an integrated T7 promoter sequence followed by RNA pre-
cipitationwith 2.5MLiCl. Sense and antisense strandswere
annealed by incubation at 95◦C for 5 min followed by slow
cooling to room temperature. Annealed dsRNAs were sub-
sequently digested with 10 U/g RNase T1 to obtain ds
siRNAs with 2 nt 3′ overhangs. RNase T1 digested siR-
NAs were purified by native 20% polyacrylamide gel elec-
trophoresis and eluted from the gel overnight at 4◦C in
elution buffer (300 mM NaCl, 2 mM EDTA) followed by
ethanol precipitation. To obtain siPools with 30 siRNAs,
siPool #1 was mixed with siPool #2, and to generate siPool
45 with 45 different siRNAs, siPool #1 was mixed with
siPool #2 and #3. siPool 60 containing 60 different siRNAs
was mixed by the use of all four different siPools #1, #2,
#3 and #4. TNRC6A, TNRC6B, TNRC6C and unspecific
control siPools (neg. pools) each comprised of 30 individual
siRNA sequences. For all template and siRNA sequences,
see Supplementary Material. Ready-to-use siPools against
various genes were purchased from siTools Biotech, Mu-
nich, Germany.
siRNA sequences and low-complexity pool generation
Antisense strands of siRNA sequences were depicted: PolG
siRNA off-T: 5′-AAUAUCCAGCGCUUCACCC-3′,
Scyl1 siRNA off-T: 5′-ACAUUGUUGUGGAUGAGGC-
3′; Mad2 siRNA: 5′-CCAAUCUUUCAGUUGUUCC3′;
neg. ctrl. siRNA: 5′-UUGUCUUGCAUUCGACUAA-
3′. esiRNAs (Sigma) were delivered as RNase
III digested double-stranded products derived
from the following sequences, PolG esiRNA: 5′-
GGAAGAAGTGGGAGGTGGTTGCTGAACGGG
CATGGAAGGGGGGCACAGAGTCAGAAATGTTC
AATAAGCTTGAGAGCATTGCTACGTCTGACAT
ACCACGTACCCCGGTGCTGGGCTGCTGCATCA
GCCGAGCCCTGGAGCCCTCGGCTGTCCAGGAA
GAGTTTATGACCAGCCGTGTGAATTGGGTGGT
ACAGAGCTCTGCTGTTGACTACTTACACCTCATG
CTTGTGGCCATGAAGTGGCTGTTTGAAGAGT-3′,
Scyl1 esiRNA: 5′-CAGCCGAGAAGCAAAAATTCTT
CCAGGAGCTGAGCAAGAGCCTGGACGCATTCC
CTGAGGATTTCTGTCGGCACAAGGTGCTGCCC
CAGCTGCTGACCGCCTTCGAGTTCGGCAATGC
TGGGGCCGTTGTCCTCACGCCCCTCTTCAAGG
TGGGCAAGTTCCTGAGCGCTGAGGAGTATCAG
CAGAAGATCATCCCTGTGGTGGTCAAGATGTT
CTCATCCACTGACCGGGCCATGCGCATCCGCC
TCCTGCAGCAGATGGAGCAGTTCATCCAGTAC
CTTGACGAGCCAACAGTCAACACCCAGATCTT
CCCCCACGTCGTACATGGCTTCCTGGACACCA
ACCCTGCCATCCGGGAGCAGACGGTCAAGTCC
ATGCTGCTCCTGGCCCCAAAGCTGAACGAGGC
CAACCTCAATGTGGAGCTGA-3′.
To generate low-complexity pools, the following siRNAs
were used: PolG siRNA 1: 5′-UCAUCCGACAGCCGAU
ACC-3′, PolG siRNA 2: 5′-AAUUCUUGCAGGUCCC
ACU-3′, PolG siRNA 3: 5′-GCUAUUACCAUCCUUG
UGA-3′, PolG siRNA 4: 5′-UUAAACUGCAUUAGUA
AGC-3′. Scyl1 siRNA 1: 5′-UUUCUCAGGAUCUACA
GUGAG-3′, Scyl1 siRNA 2: 5′-UUGAGGUAUAUUCC
CAACGGG-3′, Scyl1 siRNA 3: 5′-UUGGUUUCUACA
AAGCGGUUG-3′, Scyl1 siRNA 4: 5′-UUGUACAAUA
AAUACAUCUGU-3′. Three siRNAs were mixed in dif-
ferent combinations with the corresponding siRNA off-T
to obtain four different siRNA-containing low-complexity
pools with possible Mad2 off-target effects. For pool #1,
siRNA 1, 2, 3; for pool #2, siRNA 1, 2, 4; and for pool
#3, siRNA 1, 3 and 4 were mixed with off-T siRNAs. Low-
complexity pools consisting of siRNA 1–4 were used as
non-Mad2 off-target controls (pool #4).
Cell culture and transfections
HeLa cells were cultivated in Dulbecco’s modified Eagle’s
medium substituted with 10% FCS (fetal calf serum) and
penicillin/streptomycin. siRNA transfections were done us-
ing Lipofectamine RNAiMax (Life Technologies) accord-
ing to the manufacturer’s protocol. Cells were harvested 24
h or 48 h after transfection.
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qPCR and western blot
RNA was isolated 24 h after transfection followed by
cDNA synthesis and quantitative polymerase chain re-
action (qPCR). Following primers were used: PolG for:
5′-TTCCAGGACCTGATGCAGTA-3′, PolG rev: 5′- AC
AGGCAGGTAGGAGACACC-3′, Scyl1 for: 5′-CTGG
AGGAAGTGGAGAAGGA-3′, Scyl1 rev: 5′-TCAGCT
TGGAGGTGAGTGAG-3′, Mad2 for: 5′-AGATGACA
GTGCACCCAGAG-3′, Mad2 rev: 5′-TCCAACAGTG
GCAGAAATGT-3′ GAPDH for: 5′-ATGGGTGTGAAC
CATGAGAA-3′, GAPDH rev: 5′-GTGCTAAGCAGT
TGGTGGTG-3′, TNRC6A for: 5′-CCCTCAGGTTCC
AGTTTCAT-3′, TNRC6A rev: 5′-GCTGGTTTAGCTGG
GATAGC-3′, TNRC6B for: 5′-ATGGTTCTGGCTTCAG
CTCT-3′, TNRC6B rev: 5′-CATATTGGCTTCCTGTGT
GG-3′, TNRC6C for: 5′-TAGCAAGCATGGTGCTAT
CC-3′, TNRC6C rev: 5′-GTACCGGCCATAGGAGTC
AT-3′, OAS1 for: 5′-TGCCATTGACATCATCTGTG-3′,
OAS1 rev: 5′-GAGCCACCCTTTACCACCT-3′, INFB1
for: 5′-AGTAGGCGACACTGTTCGTG-3′, IFNB1 rev:
5′-GAAGCACAACAGGAGAGCAA-3′, IL6 for: 5′-AA
TGAGGAGACTTGCCTGGT-3′, IL6 rev: 5′-GCAGGA
ACTGGATCAGGACT-3′, STAT1 for: 5′-AATTGACC
TCGAGACGACCT-3′, STAT1 rev: 5′-CACATGGTGG
AGTCAGGAAG-3′.
For western blot analysis cells were harvested and lysed
in NET buffer (50 mM Tris pH 7.4, 150 mM NaCl, 5
mM EDTA, 0.5% NP40, 10% glycerol) 48 h after transfec-
tion. Proteins were separated via sodium dodecyl sulphate-
polyacrylamide gel electrophoresis followed by semi-dry
electroblotting. Following antibodies were used: polyclonal
anti-MAD2 (Bethyl Laboratories) at a dilution of 1:5000
and a monoclonal mouse anti beta actin antibody (clone
AC15 from Abcam) at a dilution of 1:5000 in TBS-Tween
with 5%milk powder. Fluorescently labeled IRDye 800 CW
antibodies were used as secondary antibodies (Li-COR).
Western blots were imaged with an Odyssey Fluorescence
scanner (Li-COR).
Dual luciferase assay
To generate an off-target reporter construct, a mod-
ified pMIR dual luciferase reporter plasmid (26) was
used. The 3′-UTR of Mad2 was amplified by PCR
and cloned into the corresponding SacI and PmeI
sites of pMIR. Following primers were used: Mad2-for
5′-GATCGAGCTCGGATGACATGAGGAAAATAA-
3′ and Mad2-rev 5′-GATCGTTTAAACAAGACA
AATTTAAAACAAACTTA-3′. To analyze the role
of TNRC6 family member knockdown, luciferase
assays were performed using pmir-RL-TK with
HMGA2 3′-UTR and a HMGA2 3′-UTR with mu-
tated let-7 miRNA binding sites (27). As positive
control, 2′OMe inhibitors targeting let-7a miRNA
(r[2′OMe](AACTATACAACCTACTACCTCA)dT) or
a scrambled sequence (r[2′-OMe](GCCAAGUGUUAA
AGGCCAAACUACGUUGAGAG)dT) were used. HeLa
cells were transfected in 96 well plates with 1, 3 or 10 nM
siRNAs and 20 ng 3′-UTR plasmid using Lipofectamine
2000 (Life Technologies). Cells were harvested and lysed
in passive lysis buffer (Promega) 24 h after transfection.
Firefly/Renilla luminescence ratios were normalized to
corresponding ratios of the empty pMIR plasmid or to
HMGA2 mutant vector.
Co-immunoprecipitation and northern blotting
HeLa cells were transfected with 10 nM siPools and
lysed in NET buffer (50 mM Tris pH 7.4, 150 mM
NaCl, 5 mM EDTA, 0.5% NP40, 10% glycerol) 48 h
after transfection. Lysates were used for Ago2-siRNA
co-immunoprecipitation. Protein-G sepharose beads
(GE) were pre-incubated with monoclonal anti-Ago2
(11A9) antibody (28). Lysates were incubated with
the Ago2 antibody-coupled beads for 4 h at 4◦C. Im-
munoprecipitations were subsequently washed with
NET buffer followed by proteinase K digestion and
phenol/chloroform extraction of bound RNAs. Northern
blot was performed as described earlier (29). As probes
for siRNA detection, antisense DNA oligos for the
corresponding off-T siRNAs were used: PolG Pool #1
siRNA off-T guide: 5′-GGGTGAAGCGCTGGATATT-
3′, PolG Pool #1 siRNA off-T passenger: 5′-
AATATCCAGCGCTTCACCC-3′, Scyl1 Pool #1
siRNA off-T guide: 5′-GCCTCATCCACAACAATGT-
3′, Scyl1 Pool #1 siRNA off-T passenger: 5′-
ACATTGTTGTGGATGAGGC-3′.
Transcriptome-wide gene expression analysis
HeLa cells were transfected with 3 nM Scyl1 siRNA, Scyl1
siPool 15, Scyl1 siPool 60, or mock transfected in three bi-
ological replicates. RNA was isolated 48 h after transfec-
tion and further processed for Affymetrix Human Gene 1.0
ST array analysis. The Human Gene 1.0 ST array platform
from Affymetrix (Santa Clara, CA, USA) was used to as-
sess transcriptome-wide expression profiles. Normalization
of raw intensity values from CEL files was performed us-
ing variance stabilization (30), and the median polish was
used to summarize individual probes to an expression level
per transcript. Transcripts were defined with a custom chip
description file based on Ensembl transcript identifiers (31).
The normalized data on transcript level allow for distin-
guishing between transcripts with different 3′-UTRs of the
same gene. From the 134 429 different transcripts only the
transcripts annotated as ‘protein-coding’ in the Ensembl
genes database, version 69, were retained. This yielded 78
622 transcripts. Non- and low-expressed transcripts were
then filtered out before testing for differential expression by
requiring at least two expression values of the 12 samples
of the data sets to be above the 40th percentile of all ex-
pression values. Differential transcript expression between
cells treated with one or more siRNAs and untreated cells
was estimated using limma (32). Because a large number
of tests were performed for differential expression, false
positive findings were controlled with the false discovery
rate (FDR). Instead of multiple testing adjusted P-values,
so-called q-values are reported which indicate the largest
FDR at which the transcript could be considered signifi-
cant. Transcripts with a q-value below 10−6 were considered
significant differentially expressed.
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MCF7 cells were transfected with 3 nM Scyl1 siPool 60,
Scyl1 esiRNA (Sigma), or mock transfected in three bio-
logical replicates. RNA was isolated 48 h after transfection.
Transcription profileswere analyzed using theHumanGene
2.0 ST array platform (Affymetrix). Raw intensity values
(from CEL files) were normalized using RMA (oligo (33)).
The nsFilter method from genefilter was used to remove
the 50% of features with lowest variability. Probe-to-gene
mappings were taken from hugene20sttranscriptcluster.db.
Probes not mapping to an NCBI Gene ID were removed
from the analysis, leaving 9518 genes for differential ex-
pression analysis. Differentially expressed genes were deter-
mined using limma, with a q-value cutoff of 10−3. GO over-
representation analysis of differentially expressed genes was
performed using HTSanalyzeR (34). All log2 fold changes
reported are in the form of siRNA experiment versus con-
trol.
Analyses were performed within the statistical program-
ming environment R and using Bioconductor (35) pack-
ages.
Sequence analysis
Human 3′-UTR sequences were retrieved from Ensembl
version 68 for the transcripts represented on the cartridge
microarray. The reverse compliment of the siRNA seed se-
quences (7 nt) was searched for in the 3′-UTRs of the tran-
scripts and 2292 transcripts with a seed sequence match
were found. To analyze whether there is significant enrich-
ment of transcripts with a seed-binding site among the re-
pressed transcripts after siRNA transfection, the number of
repressed transcripts with a seed match was compared to
the mean number of transcripts with a random seed match.
Seven thousand five hundred random seed sequences were
drawn and from these, 2000 with similar numbers of tran-
scripts with a seed match in the 3′-UTR (range 1692–2892
transcripts per sequence) were drawn and the number of re-
pressed transcripts with a seedmatchwere recorded for each
random seed sequence. The distribution of these values was
used to calculate the P-value for the number of repressed
transcripts with a seed match for the Scyl1 siRNA to be-
long to the same distribution. For the pool 15 and pool 60,
three additional siRNA seed sequenceswere drawn from the
pools and tested analogously.
RESULTS
Enzymatic production of highly complex siRNA pools
We hypothesized that siRNA pools containing up to 60 in-
dividual siRNAs against one target possess very low off-
target effects because of the very low concentration of each
individual siRNA. However, chemical synthesis of high
numbers of siRNAs is cost-intensive and therefore not prac-
ticable. Therefore, we set out to generate complex siRNA
pools enzymatically. For our experiments, we chose the hu-
man target genes PolG and Scyl1. siRNAs with strong off-
target effects against the geneMAD2 had been reported for
both genes (36). These siRNAs represent ideal test cases for
further downstream experiments on off-target effects (see
below).
Figure 1. siPool generation and on-target activity. (A) Schematic overview
of siPool construction. SiRNA sequences are designed and arranged in
tandem separated by specific spacer sequences. siPool transcripts are in
vitro transcribed by T7 polymerase and annealed. The resulting siPool
precursors contain complementary siRNA sequences flanked by single-
stranded spacer regions. The spacer sequences allow RNase T1 digestion
resulting in double-stranded siRNAs with 2 nt 3′ overhangs. (B) In vitro
transcription and annealing of siPools. 600 ng (left) or 800 ng (right) in
vitro transcribed (IVT) sense and antisense strands (lanes 1 and 2) were
annealed to a double-stranded siPool precursor (lane 3), loaded onto a 5%
native polyacrylamide gel (left) or on a 1% native agarose gel (right). (C)
Comparison of purified siPools with a synthetic siRNA. 50, 100 or 200 ng
of purified siPools (lanes 4–9) or a synthetic siRNA (lanes 1–3) was loaded
onto a 20% native polyacrylamide gel and visualized by ethidium bromide
staining. (D and E) HeLa cells were transfected with 1, 3 or 10 nM concen-
trations of siPools containing 15 siRNAs (pool 15 #1–4), a combination of
all 15 siRNA-siPools resulting in a siPool containing 60 different siRNAs
(pool 60) or specific siRNAs (#1–4) directed against PolG (D) or Scyl1 (E).
For siRNA pool production, we selected siRNA se-
quences using standard siRNA prediction tools, which are
connected by non-complementary linker sequences (Figure
1A). The DNA template containing the siRNA and linker
sequences contain T7 promoters to allow for the transcrip-
tion of two RNA strands, which are complementary over
the siRNA sequences but not the linkers. G nucleotides
placed at appropriate positions within the linker regions al-
low for specific digestion with the endonuclease T1, an en-
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zyme that cleaves after G only in single-stranded RNA. T1
treatment results in siRNAs with 2 nt 3′ overhangs (Figure
1A).
The two strands were transcribed, annealed and ana-
lyzed on a native polyacrylamide (PAA) gel (Figure 1B, left
panel) or a native agarose gel (right panel). In all cases, dis-
tinct bands were observed that were readily annealed to the
bulged dsRNA as evident from a size shift and enhanced
ethidium bromide staining intensity.
The ds siRNA precursors were now incubated with the
endonuclease T1 (Figure 1C). T1 treatment resulted in a
complete disappearance of the precursor and the appear-
ance of a distinct, 21 nt long cleavage product, which was
further purified by gel purification. Our siPool production
procedure combining in vitro transcription andT1 digestion
produces siRNAs that are not distinguishable from com-
mercially available synthetic siRNAs (Figure 1C).
Complex siRNA pools show highly efficient on-target activity
In order to demonstrate the functionality of siPools, we
generated four different pools against PolG (Figure 1D) or
Scyl1 (Figure 1E), each containing an individually defined
set of 15 siRNA sequences (pool #1–4). The individual as
well as the combined pools (pool 60) were transfected into
HeLa cells in three different concentrations and the knock-
down was measured on the mRNA level by qPCR. In ad-
dition, four synthetic siRNAs against PolG or Scyl1 were
transfected using the same concentrations. At all concentra-
tions used, the siRNA pools as well as the individual syn-
thetic siRNAs against PolG or Scyl1 show similar on-target
activity. This is also observed when IC50 values are deter-
mined (Supplementary Figure S1). The synthetic siRNA#4
against PolG, however, appears to be less efficient. Thus, our
enzymatically produced complex siRNA pools are as effi-
cient as synthetic siRNAs and can be broadly used for gene
knockdown experiments.
Simultaneous knockdown of redundant gene family members
The convenient production procedure as well as the effi-
cient knockdown prompted us to ask whether we can knock
down redundant gene family members using a single siPool.
For our analysis, we chose the human TNRC6 protein fam-
ily comprising TNRC6A, TNRC6B and TNRC6C. These
proteins are downstream factors of Ago proteins and are
essential for miRNA-guided gene silencing (25). We gener-
ated siPools against the individual TNRC6 proteins (Fig-
ure 2A, siPool A, B and C) and also combined them to
one siPool (siPool ABC). All siPools knocked down their
individual on-targets without affecting the mRNA levels of
the other TNRC6 gene (Figure 2A and B). Single siRNAs
knocked down the TNRC6 genes as well but showed rather
variable efficiencies (Figure 2A). Strikingly, the siPool ABC
targeting all TNRC6 genes indeed reduced the mRNA lev-
els of each family member efficiently (Figure 2A). We next
tested the consequences of TNRC6 gene knockdown on en-
dogenous miRNA function using miRNA reporter assays
based on a luciferase gene controlled by the HMGA2 3′-
UTR (Figure 2C). This 3′-UTR contains seven let-7a bind-
ing sites and is repressed by the miRNA machinery (37).
Figure 2. siPools efficiently knock down redundant gene family mem-
bers. (A) HeLa cells were transfected with 3 or 10 nM concentrations of
siPools targeting TNRC6A (‘A’, left panel), TNRC6B (‘B’, middle panel),
TNRC6C (‘C’, right panel) or a combination of all three siPools (‘ABC’).
Specific siRNAs against TNRC6A, TNRC6B or TNRC6C were trans-
fected in similar concentrations. As a negative control for TNRC6 tar-
geting siPools, an unspecific control siPool, and for siRNAs an unspe-
cific control siRNA, was used. mRNA levels were measured by qPCR
and normalized to GAPDH, and relative expression levels were calcu-
lated based on transfection of an unspecific control siPool or an unspe-
cific control siRNA (ctrl.). (B) siPools specifically knock down individ-
ual family members. HeLa cells were transfected with 3 nM concentra-
tions of siPools targeting TNRC6A (‘A’), TNRC6B (‘B’), TNRC6C (‘C’)
or a combination of all three siPools (‘ABC’). mRNA levels of TNRC6A
(left panel), TNRC6B (middle panel) or TNRC6C (right panel) were mea-
sured by qPCR and normalized to GAPDH. Relative expression levels
were calculated based on transfection of an unspecific control siPool or
an unspecific control siRNA (ctrl.). (C) Dual luciferase assay: HeLa cells
were co-transfected with HMGA2 3′-UTR dual luciferase expression vec-
tor and with 3 or 10 nM siRNAs, or siPools targeting TNRC6A (T6A),
TNRC6B (T6B), TNRC6C (T6C) or a combination of all siPools target-
ing TNRC6A, TNRC6B and TNRC6C (T6 ABC). As positive control we
used a let-7a 2′OMemiRNA inhibitor which was normalized to an unspe-
cific control 2′OMe inhibitor (ctrl.). Relative luciferase activity was calcu-
lated using the ratio for firefly/Renilla luciferase and via normalization to
the corresponding ratios of an HMGA2 3′-UTRwith mutated let-7a bind-
ing sites. All ratios were further normalized to a corresponding unspecific
negative control (ctrl.) siPool or siRNA. (D) qPCR analysis of TNRC6A,
TNRC6B and TNRC6C expression levels relative to GAPDH in HeLa
cells.
Inhibition of let-7a by antisense inhibitors leads to a relief
of repression (gray bar) indicating that the reporter system
is indeed under the control of let-7a. Since TNRC6 proteins
are mediators of miRNA-guided gene silencing, we hypoth-
esized that knockdown of these proteins should lead to a
block of miRNA-guided repression and thus increased lu-
ciferase signals. Consistently, knockdown of TNRC6A or
B either by the siPools or by individual siRNAs relieved
repression and led to an increase of luciferase activity of
about 1.5–1.8-fold (Figure 2C). Knockdown of TNRC6C
alone had only a minor effect on luciferase activity. Of note,
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TNRC6C expression is much weaker in the HeLa cells that
have been used and this might explain the stronger varia-
tion of the TNRC6C measurements (Figure 2A, B and D).
Simultaneous knockdown of all three family members by
the siPool ABC released repression by 2.3- to 2.5-fold, a
similar range observed by the antisense inhibitor against
let-7a. Thus, an increased effect compared to the single
knockdowns indicates that the three human proteins func-
tion redundantly on the HMGA2 reporter. In summary, we
demonstrate that siPools can be used for efficient knock-
down of redundant gene family members and, furthermore,
the siPool ABC against all TNRC6 genes is a valuable con-
trol tool for experiments aiming at identification of miRNA
target genes.
Complex siRNA pools do not cause measurable off-target ef-
fects
To directly test our hypothesis that off-target effects of in-
dividual siRNAs are eliminated in complex siRNA pools,
we took advantages of the known off-target effect against
MAD2 of the abovementioned siRNAs against PolG or
Scyl1 (36). To ensure that the off-target siRNAs were in-
deed present in our pools, we transfected the 60 siRNA-
containing pools against PolG or Scyl1 into HeLa cells and
immunoprecipitated Ago2 from the cell lysates (Figure 3A).
The off-target siRNAs were analyzed by northern blotting
using probes against the guide (upper panel) or the passen-
ger strand (lower panel). The guide strand was readily de-
tectable in Ago2 complexes indicating that siRNAs are ef-
ficiently processed and loaded and our siPools can be used
for further off-target analysis.
Next, we reproduced the described Mad2 off-target ef-
fect (Figure 3B). Consistent with the published literature,
both the siRNA against PolG (siRNA off-T, left panel) and
the siRNAagainst Scyl1 (siRNAoff-T, right panel) strongly
reduced Mad2 mRNA levels when transfected into HeLa
cells. We next placed the same siRNAs into a siRNA pool
containing 14 (siPool 15) or 59 (siPool 60) additional siR-
NAs (Figure 3B, blue and green columns). The pools were
transfected into HeLa cells and MAD2 mRNA levels were
measured by qPCR. Strikingly, the MAD2 off-target effect
of the two siRNAs was markedly reduced when 15 siR-
NAs were combined and hardly measurable when 60 siR-
NAs were used. To further solidify our results, we ana-
lyzed Mad2 protein reduction by PolG and Scyl1 siRNA
off-target effects (Figure 3C). HeLa cells were transfected
with siRNAs against PolG (left panel: siPools 15 and 60,
single siRNA off-T) or Scyl1 (right panel: siPools 15 and
60, single siRNA off-T). Cells were lysed and protein ex-
tracts were analyzed by western blotting against MAD2. In
both cases, a siRNA directed against MAD2 was added for
further specificity control. In accordance with our results
on MAD2 mRNA levels, we find that both off-target siR-
NAs as well as the control siRNA directed against MAD2
strongly reduce MAD2 protein levels (left and right panels,
lanes 7–10). However, when the same off-target siRNAs are
placed in complex siRNA pools, the MAD2 protein deple-
tion is strongly reduced (left and right panels, lanes 3–6).
Figure 3. Off-target activity of different siPools. (A) HeLa cells were trans-
fected with 10 nM siPool 60. To validate that the specific off-T siRNAs are
present in the pools, Ago2 was immunoprecipitated from the lysates and
passenger and guide strands of PolG off-T (left) or Scyl1 off-T (right) siR-
NAs were analyzed by northern blotting. As positive controls, 3 pmol of
total siPools and 2.5% input material were used. (B) HeLa cells were trans-
fected with 1, 3 or 10 nM siPool 15 #1, siPool 60 or specific off-T siRNAs
directed against PolG (blue) or Scyl1 (green). Mad2 mRNA levels were
measured by qPCR and normalized toGAPDH.Relative expression levels
were calculated based on transfection of an unspecific control siRNA (neg.
ctrl.). (C) Experiment was performed as described in (B). MAD2 protein
levels were analyzed by western blotting 48 h after transfection. A specific
MAD2 siRNA served as a positive control (lanes 9 and 10). Actin expres-
sion levels were used as loading controls (lower panels). (D) HeLa cells
were transfected with 3 or 10 nM siRNA off-T or siPools containing 15,
30, 45 or 60 different siRNAs directed against PolG (blue) or Scyl1 (green).
Off-target activity was analyzed using MAD2 3′-UTR controlling firefly-
luciferase activity. Relative luciferase activity was calculated using the ratio
of firefly/Renilla luciferase and via normalization to the corresponding ra-
tios of the empty control vector.
Off-target effects are lost in a luciferase reporter system
To further solidify our data, we generated luciferase re-
porters containing miRNA-like binding sites for the PolG
off-target siRNA or the Scyl1 off-target siRNA (Figure
3D). The single off-target siRNAs were transfected into
HeLa cells and a reduction of the luciferase activity was ob-
served (left and right panels, siRNA off-T). However, when
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the siRNAs were part of complex siRNA pools, the reduc-
tion of the luciferase activity was abolished. Furthermore,
we analyzed the complexity requirements of the pools for
off-target elimination. While the Scyl1 off-target effect was
already eliminatedwhen 15 siRNAswere used, the effects of
the PolG pools were slightly stronger in pools with higher
complexity (left panel, compare pool 15 with pool 30), sug-
gesting that approximately 30 siRNAswithin a pool are suf-
ficient for off-target elimination. In summary, using inde-
pendent approaches we demonstrate that off-target effects
of individual siRNAs can be strongly reduced by combining
multiple siRNAs to complex pools.
siPools affect global transcript levels less than single siRNAs
We next investigated effects of single siRNAs or siPools on
global mRNA levels using microarrays (Figure 4A and B).
The Scyl1 siRNA with off-target against MAD2 or siPools
containing 15 or 60 siRNAs were transfected into HeLa
cells and global mRNA changes were analyzed. Mock
transfection served as control. The single siRNA against
Scyl1 reduced the levels of all Scyl1 transcripts efficiently
(Figure 4A, left panel, green circles). However, MAD2 and
many other transcripts were also strongly reduced. When
siPools containing 15 (middle panel) or 60 (right panel) siR-
NAs were used, Scyl1 transcripts were efficiently knocked
down as well but Mad2 remained unaffected. Furthermore,
global transcript levels were affected only mildly when 15
siRNAs were used and almost no alterations were observed
when the 60 siRNA siPool was transfected. Focusing on the
repressed transcripts after single siRNA or siPool transfec-
tion, transcripts with a Scyl1 siRNA complementary seed
sequence in the 3′-UTR are significantly enriched in the sin-
gle siRNA transfection experiment (P = 3 × 10−16), but
not in the siPool transfections (Figure 4B). Therefore, our
siPool strategy not only depletes the on-target transcripts
very efficiently, but also perturbs global transcript levels
only marginally.
It is conceivable that a single siRNAwithin the pool con-
tributes strongly to the on-target activity. Thus, a potent
siRNA could simply be diluted with a standard off-target
pool to reduce off-target effects. To test this directly, we
mixed a potent siRNA against Scyl1 with an unrelated con-
trol siPool and compared the on-target activity of the pool
with the activity of the single siRNA (Figure 4C).We clearly
observe that a simple dilution of a potent siRNA with un-
related siRNAs causes a dramatic loss of on-target activity.
This is also observedwhen IC50 values are determined (Fig-
ure 4D). As expected, off-target effects are strongly reduced
by siRNA dilution (Supplementary Figure S2). Thus, all
siRNAs within a complex pool contribute to on-target ac-
tivity and complex siPools against one mRNA target over-
come off-target effects without the loss of on-target activity.
Comparison of complex siRNA pools with commonly used
siRNA reagents
Various RNAi reagents are available including synthetic
single siRNAs, RNase III generated siRNAs from long
dsRNA precursors (esiRNAs) (38) or siRNA pools with
low complexity containing only four synthetic siRNAs
(smart pools). To evaluate our siPools with respect to other
RNAi tools, we compared on- and off-target effects of com-
mercially available RNAi reagents with our siPools (Fig-
ure 5). We first tested PolG on-target activities (Figure 5A,
upper panel). A single siRNA (off-T siRNA; MAD2 off-
target), an esiRNA pool, four low-complexity pools (#1–
3 contain the off-T siRNA) as well as siPools with 15 or
60 siRNAs were transfected and PolG mRNA levels were
measured using qPCR. As expected, all reagents show sim-
ilar PolG knockdown efficiency. When MAD2 mRNA lev-
els were analyzed, the off-target siRNA efficiently silenced
the Mad2 mRNA as well (lower panel). Also, when placing
the off-target siRNA into low-complexity pools (#1–3), the
off-target activity was slightly reduced but still readily de-
tectable. In agreementwith our previous results, our 15 or 60
siRNAs containing siPools eliminated theMAD2 off-target
effect. Of note, low-complexity pool #4 does not contain
the off-target siRNA and serves as control in this experi-
ment. esiRNAs, which resemble a random mixture of short
dsRNA fragments from a long double-stranded precursor
RNA, do not contain the specific Mad2 off-T siRNA and
were therefore not included. Similar results were obtained
when the Scyl1 off-target siRNA was used (Figure 5B). Fi-
nally, we utilized the abovementioned luciferase reporter
system carrying a miRNA-like binding site for the PolG
and Scyl1 off-target siRNAs (Figure 5C, upper and lower
panels). Consistent with the mRNA data, our siPools elim-
inated off-target effects in this assay, while low-complexity
pools (#1–3) led only to a moderate reduction. Taken to-
gether, our data demonstrate that while on-target silencing
of siPools matches the efficiency of commercially available
single siRNAs or low-complexity pools, only siPools elimi-
nated off-target effects in these experiments.
siPools do not cause measurable interferon responses
Since siPools and esiRNAs derive from longer dsRNA
precursors and such precursors might cause interferon re-
sponse, we tested the expression of interferon response
genes after siRNA transfection (Figure 6). siPools against
four different targets (PolG, Scyl1, Traf5 and Ago2) were
compared to the corresponding commercial esiRNAs ob-
tained from Sigma. While siPools show distinct 21 nt long
bands, all purchased esiRNAs were characterized by an
RNA smear ranging from 15 to more than 40 nt (Figure
6A). For interferon response experiments, we changed to
MCF7 cells, as HeLa cells are known to be rather insensi-
tive to interferon inducing agents. All four target genes were
efficiently knocked down by the siPools, while the esiRNA-
mediated knockdown was slightly less efficient (Figure 6B
and C, left panels, and Supplementary Figure S3). We next
analyzed the expression of the interferon response genes
IFNB1 and OAS1 upon knockdown. While siPools did not
cause expression of IFNB1 or OAS1, esiRNAs led to a
strong (Scyl1, PolG) or to a medium to low (Traf5, Ago2)
interferon response (Figure 3B and C and Supplementary
Figure S3). Similar results were obtained when the inter-
feron response genes IL6 and STAT1 were measured (Sup-
plementary Figure S4). For a broader overview, we ana-
lyzed global mRNA changes upon esiRNA or siPool trans-
fection in MCF7 cells (Figure 6D). While transfection of
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Figure 4. Global mRNA expression profiles upon siRNA transfection. HeLa cells were transfected with 3 nM of a Scyl1-targeting siRNA and siPools.
(A) Differential mRNA expression in the single siRNA, pool of 15 sequences and pool of 60 sequences experiment. The horizontal axis shows the average
expression level over siRNA-treated and control experiments, and the vertical axis shows the difference in expression between treated and control samples
(log2 fold change). Transcripts differentially expressed at a q-value of 10−6 are highlighted in red, and all others are shown in gray. Scyl1 transcripts are
highlighted in green,Mad2 (isoformMAD2L1 was targeted) in black. The siRNA experiment induces more genes to change expression levels than the pool
experiments. The off-target MAD2L1 is significant differentially expressed in the siRNA experiment, but not in the pool experiments. (B) Enrichment of
seed complementary sites in the 3′-UTRs of repressed transcripts.White bars show the number of repressed transcripts with a Scyl1 siRNA complementary
seed sequence in the single siRNA (siRNA) and the pool of 15 (pool 15, bar labeled siPool15 1) and 60 sequences (pool 60, bar labeled siPool60 1). Gray
bars show the mean number of repressed transcripts in the respective experiment with a complementary site to a random seed sequence. The enrichment in
the single siRNA transfection experiment is significant with P<< 0.001, while the same sequence as well as three additional randomly chosen sequences of
the pools are not significantly enriched in the repressed transcripts. (C andD) Activity of single siRNAs as part of negative control siPools. HeLa cells were
transfected with indicated concentrations in nM of Scyl off-T siRNA alone or mixed in an unspecific ctrl. siPool to an equal concentration of individual
siRNAs of the siPool. IC50 values are depicted in the line graph (C); in addition, data are also shown in a bar graph (D). mRNA levels were measured via
qPCR and normalized to GAPDH.
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Figure 5. Comparison of siPools with other available RNAi reagents. qPCR analysis of on- (left panels in (A) and (B)) and off-target (right panels in (A)
and (B)) activities of various siRNA tools. HeLa cells were transfected with 1 or 3 nM siPool 15, siPool 60, single off-T siRNA, esiRNAs and four different
low-complexity pools directed against PolG (A) or Scyl1 (B). mRNA levels were normalized to GAPDH and relative expression levels were calculated
using a negative control siRNA. Low-complexity pool #4 served as a MAD2 off-target negative control. (C) HeLa cells were transfected with 1, 3 or 10
nM siRNA off-T, siPools with 15 or 60 different siRNAs and four different low-complexity pools directed against PolG (blue) or Scyl1 (green). Off-target
activity was analyzed using a reporter system based on firefly-luciferase activity controlled by theMAD2 3′-UTR. Relative luciferase activity was calculated
using the ratio of firefly/Renilla luciferase and via normalization to the corresponding ratios of the empty control vector. Low-complexity pool #4 served
as a MAD2 off-target negative control.
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Figure 6. Analysis of interferon response induction. (A) 400 ng of esiRNAs or 200 ng siRNA pools both against Scyl1, PolG, Traf5 and Ago2 were loaded
onto a 20% native PAA gel and stained with ethidium bromide. (B and C) MCF7 cells were transfected with 1, 10 or 30 nM siPools or corresponding
esiRNAs against Scyl1 (B) or PolG (C). mRNA levels were normalized to GAPDH and relative expression levels were calculated using a negative control
siPool. (D) MCF7 cells were transfected with 10 nM esiRNAs (left) or a siPool containing 60 siRNAs (right) against Scyl1. mRNA expression profiles
were assessed using microarray.
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a siPool containing 60 siRNAs did not lead to obvious
mRNA changes except for the on-target Scyl1 (right panel),
the esiRNA triggered severe alterations in transcript levels
(left panel). Interestingly, a large part of the up-regulated
mRNAs originates from interferon response genes (Supple-
mentary Table S1). Together, our data suggest that esiRNAs
can trigger the cellular interferon response due to the longer
dsRNA fragments they contain. This is not observed for
siPools.
DISCUSSION
Off-target effects are a severe but often ignored error source
in RNAi experiments. This is particularly important for
genome-wide screening approaches, in which only a num-
ber of hits can be validated individually (39–41). In fact,
it has been reported that in an RNAi screen for cell cycle
regulators, MAD2––a key protein in this process––was fre-
quently off-targeted leading to great numbers of false pos-
itives (36). These observations underscore the urgent need
of RNAi reagents without off-target effects.
The reduction of off-target effects has been a major di-
rection in RNAi research since such effects had been rec-
ognized (41). A widely used strategy to reduce off-target
effects is the introduction of chemical modifications into
guide and passenger strands. 2′-O-methylation of the guide
strand leads to a reduction of miRNA-like off-target ef-
fects presumably due to less efficient binding to the seed
sequence of the off-target mRNA. For siRNA on-target ac-
tivity, this modification seems to be tolerated (42). In addi-
tion to 2′-O-methyl groups, locked nucleic acids or deoxynu-
cleotides have been used and off-target reduction was also
observed (43,44). A systematic screen for suitable chemical
modifications found that destabilizing unlocked nucleic acid
modifications at position 7 of the guide strand resulted in
significantly reduced off-target effects (45,46). Moreover, it
has also been reported that the utilization of miRNA-like
siRNAs, i.e. mismatched miRNA/miRNA* duplexes, pos-
sess potent on-target activity but approximately 10-fold re-
duced off-target effects (47,48). Since both the guide and
the passenger strand can cause off-target effects, it has been
demonstrated that passenger strand loading and thus all po-
tential passenger strand mediated off-target effects can be
reduced by using a fragmented passenger strand (referred
to as sisiRNAs) or by blocking the 5′ end of the passen-
ger strand by methylation (49,50). Taken together, numer-
ous chemical modifications at many different positions of
the guide as well as the passenger strand have been intro-
duced (reviewed in (51)) and these alterations have signif-
icantly improved siRNA specificity and reduced miRNA-
like off-target effects. However, despite all these improve-
ments, particularly siRNA screens still generate high num-
bers of false positives mainly due to off-target effects (52)
highlighting the need of further siRNA specificity improve-
ments.
We present a next-generation RNAi tool that is based on
complex pools of selected siRNA sequences, which we refer
to as siPools. SiRNA mixtures are already used for RNAi
applications. These pools are generated by RNase III or
Dicer, which cleave the long dsRNAs in a stochastic pro-
cess to all possible double-stranded cleavage products (53–
55). In addition, RNase III, for example generates not ex-
clusively 21mers but also a large variety of small RNAswith
different lengths. All these unspecific RNAs can cause addi-
tional and unpredictable problems inRNAi experiments. Of
note, biochemical studies have demonstrated that a single
pointmutation inEscherichia coliRNase III generatesmore
discrete size products thus improving RNase III generated
siRNAs (56). On the other hand, defined pools contain-
ing four siRNAs are available (referred to as smart pools).
However, because of the low complexity, off-target effects
are not significantly reduced, while the on-target activity
is not improved compared to single siRNAs. Higher pool
complexities have not been used because mixing synthetic
siRNAs is rather cost-intensive and therefore not realistic
as a commercial tool. We solve this problem by an enzy-
matic siPool-production protocol, which is cheap and ro-
bust. SiPools combine the strengths of the two existing pool-
ing approaches: first, our siPools are complex enough to
dilute out the sequence-specific off-target effects and sec-
ond, siPools are accurately defined allowing for the selection
of highly potent siRNAs and target sequences leading to
highly efficient knockdown results. It should be noted that
siRNA pooling approaches might not be suitable for ther-
apeutic purposes. Authorities might not approve even well-
defined pools such as siPools because they resemble com-
plex compound mixtures.
In addition to the major step forward in eliminating off-
target effects, our siPools may have several other advan-
tages. First, redundant gene family members can be effi-
ciently targeted simultaneously. Smaller pools against each
member can be generated, which can easily be combined
to larger pools with wider but highly specific target spec-
tra. Second, whole cellular pathways might be targeted with
one siPool containing siRNAs against several key factors,
which might be located at pathway branch points. Third,
viral RNAs, which mutate rapidly and frequently escape
siRNA targeting strategies (57), could be targeted with
siPools much more efficiently. Finally, our siPool approach
would also allow for inclusion of modified nucleotides,
which could be selectively added to the in vitro transcrip-
tion reaction of the passenger strand. This would lead to
siRNAs with modified passenger strands only. Such mod-
ified siPools might be more stable when injected into ani-
mals, for example, and might therefore be ideal reagents for
in vivo studies.
Recently, a large number of long non-coding RNAs
(lncRNAs or lincRNAs) have been discovered in various
organisms and tissues (58,59). These RNAs have different
functions and are mainly involved in gene regulation at
the chromatin level. LncRNAs can be several kilobases in
length and are usually highly structured and packaged into
RNA–protein complexes. Thus, not many regions might be
accessible for knockdown experiments and it has been ob-
served that such RNAs are notoriously difficult to knock
down using single siRNAs. It is tempting to speculate that
our siPools solve this problem since enough siRNAs within
a complex mixture might find accessible binding sites on a
lncRNA.Our own preliminary data support this hypothesis
(data not shown). This might not only be possible for cyto-
plasmic lncRNAs since it has been shown that RNAi works
well in the nucleus (60,61). In summary, siPoolsmight there-
8060 Nucleic Acids Research, 2014, Vol. 42, No. 12
fore not only control off-target activity of siRNAs but could
also serve as a potent tool to inactivate lncRNAs.
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